We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

171 hedge funds and large institutions have $825M invested in SANGAMO THERAPEUTICS INC in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,317% more call options, than puts

Call options by funds: $200M | Put options by funds: $8.28M

59% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 22

21% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 48

11% more capital invested

Capital invested by funds: $742M → $825M (+$83M)

8% more funds holding

Funds holding: 158171 (+13)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
171
Holders Change
+13
Holders Change %
+8.23%
% of All Funds
4.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
58
Reduced
48
Closed
22
Calls
$200M
Puts
$8.28M
Net Calls
+$192M
Net Calls Change
+$4.26M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$66.2M +$1.87M +120,706 +3%
WA
2
Wasatch Advisors
Utah
$48M +$1.37M +88,528 +3%
BFA
3
BlackRock Fund Advisors
California
$40.9M +$1.09M +70,695 +3%
State Street
4
State Street
Massachusetts
$39.5M +$2.94M +190,274 +8%
Vanguard Group
5
Vanguard Group
Pennsylvania
$35.4M +$1.77M +114,411 +5%
FCM
6
Frontier Capital Management
Massachusetts
$34M +$4.73M +305,417 +16%
BIT
7
BlackRock Institutional Trust
California
$30M -$113K -7,276 -0.4%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$27.8M +$3.19M +206,179 +13%
JHIU
9
Janus Henderson Investors US
Colorado
$27.5M +$3.18M +205,845 +13%
Jennison Associates
10
Jennison Associates
New York
$26.9M +$66.1K +4,273 +0.2%
BBA
11
Baker Bros. Advisors
New York
$22M +$6.95M +449,212 +47%
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$20.4M -$15.5M -1,000,000 -43%
RCM
13
RA Capital Management
Massachusetts
$19.1M
Goldman Sachs
14
Goldman Sachs
New York
$16.5M +$5.2M +335,917 +47%
Invesco
15
Invesco
Georgia
$16.4M +$14.2M +914,584 +702%
EAM
16
EverPoint Asset Management
Connecticut
$14.9M -$2.32M -150,000 -14%
PA
17
Perceptive Advisors
New York
$12.5M
Northern Trust
18
Northern Trust
Illinois
$12.4M +$226K +14,633 +2%
FC
19
FIC Capital
New York
$12.3M -$16.2K -1,050 -0.1%
Millennium Management
20
Millennium Management
New York
$11.7M +$6.93M +447,971 +151%
VOYA Investment Management
21
VOYA Investment Management
Georgia
$11.5M +$2.19M +141,261 +24%
Franklin Resources
22
Franklin Resources
California
$11.2M
TCM
23
Tekla Capital Management
Massachusetts
$10.6M
Allianz Asset Management
24
Allianz Asset Management
Germany
$10.6M -$310K -20,067 -3%
CNB
25
City National Bank
California
$10.1M +$2.35M +151,950 +31%

SGMO Hedge Fund Activity: Q1 2015 in Review

171 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2015, worth a combined $825M — up 11% from $742M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 22 closed out — a net gain of 13 holders — while 58 added to existing stakes and 48 trimmed.

The largest buyer was Invesco, adding an estimated $14.2M. The largest seller was Adage Capital Partners, cutting an estimated $15.5M.

  • 171 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2015, up from 158 in Q4 2014.
  • Funds reported $825M of SANGAMO THERAPEUTICS INC stock for Q1 2015, up 11% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2015 and 22 closed out, a net change of +13 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2015 was Invesco, an estimated $14.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2015 was Adage Capital Partners, an estimated $15.5M sold.

Based on aggregated 13F filings for Q1 2015.